The Coretec Group’s Dr. Ramez Elgammal Is Selected to Present at ALD/ALE 2021
Advertisement



Business News
The Coretec Group’s Dr. Ramez Elgammal Is Selected to Present at ALD/ALE 2021
347
views

ANN ARBOR, Mich.--(BUSINESS WIRE/AETOSWire)-- The Coretec Group, Inc., (OTCQB: CRTG) (the “Company”) is proud to announce that Dr. Ramez Elgammal, Vice President of Technology at The Coretec Group, has been selected to present at the AVS 21st International Conference on Atomic Layer Deposition (ALD 2021) featuring the 8th International Atomic Layer Etching Workshop (ALE 2021) taking place next month.

The ALD/ALE conference is globally recognized in the industry as the premier event for sharing state of the art developments and is widely attended by semiconductor companies and supporting partners, including specialty gas and equipment suppliers. Dr. Elgammal’s abstract was accepted because of his exceptional knowledge in innovative ways of producing high purity silicon films at low temperatures using engineered silicon molecules.

Dr. Elgammal’s abstract: Routes to Novel Dielectric and Semiconductor Devices Using Cyclohexasilane is scheduled for Monday, June 28, 2021, 1:00 PM EST as part of Session: AF1: Precursors and Chemistry: Precursor Design, New Precursors, Process Development.

"I’m honored to have been selected to share our vision of cyclohexasilane’s potential as a preeminent silicon precursor for use in Atomic Layer Deposition processes that are used in the manufacturing of microelectronic devices. Given both the need and demand for better performing silicon and silicon dielectric-based devices, we expect our Cyclohexasilane to offer great improvements in manufacturing and performance over incumbent silicon precursors,” said Dr. Elgammal.

Dr. Ramez Elgammal is a Senior Research Associate at the University of Tennessee where he manages a broad spectrum of projects in energy storage and energy generating devices including fuel cells, flow batteries, and lithium-ion batteries. He has over 40 publications and conference proceedings and 7 patents pending. Dr. Elgammal earned his M.Sc. in applied physics and Ph.D. in chemistry at the California Institute of Technology (Caltech) as a Rosen Fellow, and holds an honor’s B.S. in chemistry from Central Michigan University where he was a Centralis Scholar.





What's your reaction?

Facebook Conversations

Disqus Conversations